Search by Drug Name or NDC
NDC 66794-0201-02 Levothyroxine Sodium 500 ug/5mL Details
Levothyroxine Sodium 500 ug/5mL
Levothyroxine Sodium is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Piramal Critical Care, Inc.. The primary component is LEVOTHYROXINE SODIUM ANHYDROUS.
Product Information
NDC | 66794-0201 |
---|---|
Product ID | 66794-201_0d19777c-1645-1abb-e063-6294a90acab8 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Levothyroxine Sodium |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Levothyroxine Sodium |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 500 |
Active Ingredient Units | ug/5mL |
Substance Name | LEVOTHYROXINE SODIUM ANHYDROUS |
Labeler Name | Piramal Critical Care, Inc. |
Pharmaceutical Class | Thyroxine [CS], l-Thyroxine [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA206163 |
Listing Certified Through | 2024-12-31 |
Package
NDC 66794-0201-02 (66794020102)
NDC Package Code | 66794-201-02 |
---|---|
Billing NDC | 66794020102 |
Package | 5 mL in 1 VIAL, SINGLE-USE (66794-201-02) |
Marketing Start Date | 2022-10-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |